Dr. Cherise Dunn

Healthcare innovation strategy for institutions moving from ambition to implementation.

Dr. Cherise Dunn advises health systems, public institutions, universities, funders, and innovation partners on responsible AI adoption, resilient health manufacturing, health equity, partnership governance, and implementation readiness.

Advises

Health systems, public institutions, universities, funders, and innovation partners.

Focus

Responsible AI adoption, resilient health manufacturing, health equity, and implementation readiness.

Proof

Harvard, UCT, G20 Startup20, BRICS, IVLP, TEDx, and MIT AI Ventures.

Selected credibility and institutional platforms

Harvard · UCT · U.S. State Department IVLP · G20 Startup20 · BRICS · TEDx · MIT AI Ventures Founder-operator credibility across healthcare innovation, public health, digital manufacturing, and global health-policy platforms.

Healthcare innovation rarely fails because the idea alone is weak. It often fails because the operating model is unclear.

Dr. Cherise Dunn helps institutions make better decisions about what to build, how to govern it, who to partner with, and how to move health innovation beyond concept papers, pilot activity, funding commitments, and public ambition.

Her work connects responsible AI adoption, resilient health manufacturing, health equity, public health, and cross-sector implementation.

She is best suited for institutions working to turn health technologies, partnerships, and equity commitments into governed, fundable, and implementable models.

Proof across healthcare innovation, manufacturing, policy, and recognition

Selected roles, platforms, awards, and institutional work with direct relevance to healthcare innovation, AI adoption, digital manufacturing, and health equity implementation.

Download Full CV

Building healthcare manufacturing capability

Co-founded and operated initiatives focused on point-of-care medical devices, digital manufacturing, local production models, and access-oriented healthcare innovation.

Turning institutional support into implementation capacity

Led funded and partner-supported initiatives that translated healthcare innovation and digital manufacturing capability into practical point-of-care production work.

Translating global partnerships into health innovation capability

Built and supported partnerships involving Stanford University, Autodesk, Formlabs, and the U.S. State Department to advance digital manufacturing and healthcare implementation.

International validation across health, policy, AI, and entrepreneurship

Selected for platforms including G20 Startup20, BRICS, IVLP, TEDx, and MIT AI Ventures, spanning health innovation, public leadership, AI, and emerging-market entrepreneurship.

Scientific depth, public-health training, and venture-building experience

Combines doctoral scientific training, Harvard public-health training, founder-operator experience, and practical venture-building across healthcare innovation and manufacturing.

Discuss a relevant institutional opportunity

For advisory, partnership, speaking, board, funder, or public-sector conversations, request an advisory conversation.

Request an advisory conversation

Advisory for healthcare innovation, AI adoption, digital manufacturing, and health equity implementation.

Dr. Dunn helps senior leaders decide where to invest, how to structure partnerships, and how to move healthcare innovation into practice.

Her background combines founder experience, Harvard public-health training, digital manufacturing work, AI adoption strategy, and experience across international health, policy, and entrepreneurship platforms.

Typical outputs include advisory memos, strategic roadmaps, partnership architecture, AI use-case prioritisation, implementation-risk reviews, stakeholder briefings, and executive workshops.

Healthcare innovation strategy

Helping institutions decide where to invest, what to build, which partnerships matter, and how to move from ambition to implementation.

AI adoption and governance in health

Supporting practical use-case selection, risk review, governance considerations, and implementation pathways for responsible AI adoption in healthcare and public-health settings.

Resilient health manufacturing capability

Advising on point-of-care production, distributed manufacturing models, medical-device pathways, and supply resilience for healthcare systems.

Health equity and access implementation

Designing strategies that connect policy intent, operational delivery, access barriers, and community needs in underserved health settings.

Cross-sector partnership architecture

Aligning public, private, university, funder, and implementation partners around clear roles, governance, delivery responsibilities, and shared outcomes.

You are evaluating an AI or digital health initiative and need a practical adoption pathway.

You are exploring healthcare manufacturing, point-of-care production, or local capability-building.

You are designing a health equity, access, or public-health innovation initiative.

You need to align public, private, university, funder, or implementation partners.

You need an expert briefing, workshop, or strategic review before committing resources.

Where Dr. Dunn’s experience is most relevant

These are the institutional contexts where Dr. Dunn’s founder, public-health, digital manufacturing, and advisory experience is most useful.

Point-of-care and distributed healthcare manufacturing

The context: Healthcare systems need more resilient ways to design, produce, and deploy medical devices closer to the point of need.

Dr. Dunn’s relevance: Founder-operator experience across point-of-care medical devices, digital manufacturing, local production models, and access-oriented healthcare innovation.

Credibility signal: Funding, technology-transfer support, and partnerships connected to healthcare manufacturing and digital production capability.

Institutional implementation and delivery readiness

The context: Promising health innovations often stall when governance, partners, operating models, and delivery responsibilities are unclear.

Dr. Dunn’s relevance: Advisor and founder experience across public health, innovation strategy, cross-sector partnerships, and implementation planning.

Credibility signal: International platform credibility across G20 Startup20, BRICS, IVLP, TEDx, and MIT AI Ventures.

Responsible technology adoption in health systems

The context: AI and advanced manufacturing tools need clear use cases, governance, equity safeguards, and implementation pathways before institutions commit resources.

Dr. Dunn’s relevance: Strategic advisory experience helping institutions assess use cases, operating models, partnership requirements, and access implications.

Credibility signal: Cross-sector credibility across public health, AI adoption, digital manufacturing, healthcare innovation, and international innovation platforms.

Who this is for

Health systems and public institutions

For teams making decisions about healthcare innovation, responsible AI adoption, manufacturing resilience, access strategy, and implementation readiness.

Universities and research partners

For institutions translating scientific, technical, or public-health work into partnerships, implementation models, and real-world adoption pathways.

Funders and innovation programmes

For organisations assessing where funding, technology transfer, and partnership support can build credible implementation capacity and access-oriented health innovation.

Boards and advisory committees

For organisations needing governance-aware perspective on healthcare innovation, responsible AI adoption, manufacturing resilience, health equity, and cross-sector implementation.

Media, conferences, and convening platforms

For interviews, panels, and public conversations on healthcare innovation, AI adoption, digital manufacturing, health equity, and emerging-market innovation.

Healthcare innovation beyond the pilot stage

Why promising health innovations often stall and what institutions need to do differently to move from pilot activity to implementation.

Responsible AI adoption in health systems

Practical use cases, governance questions, risk, equity considerations, and implementation pathways for health-sector AI.

Distributed manufacturing for healthcare resilience

How point-of-care and distributed production models can support access, supply resilience, and healthcare innovation.

Health equity, access, and implementation

How to design innovation strategies that respond to access barriers, community needs, and real-world delivery constraints.

From global innovation interest to local implementation capacity

How institutions can turn funding, partnerships, and technology transfer into practical healthcare capability in underserved settings.

Women founders and emerging-market health innovation

Lessons from building health innovation ventures across African and global platforms, with a focus on leadership, access, and implementation.

Public leadership, convening, and innovation settings

Selected public appearances across healthcare innovation, manufacturing, media, and international entrepreneurship platforms.

Dr. Cherise Dunn giving a media interview at the G20 Startup20 event in Brazil
G20 Startup20, Brazil - media interview during an international entrepreneurship and innovation platform.
Dr. Cherise Dunn speaking on a panel at Africa Tech Festival
Africa Tech Festival - panel appearance on technology, innovation, and emerging-market entrepreneurship.
Dr. Cherise Dunn on a Manufacturing Indaba 2022 panel
Manufacturing Indaba 2022 - panel participation connected to manufacturing, innovation, and local production capability.

Healthcare innovation, AI, and advisory work

Brief answers for institutions, partners, and media.

Who is Dr. Cherise Dunn?

Dr. Cherise Dunn is a founder-operator and strategic advisor working across healthcare innovation, responsible AI adoption, digital manufacturing, and health equity implementation. Her work focuses on helping institutions move promising health innovation from concept, pilot, or partnership intent into practical implementation models.

What does Dr. Dunn advise on?

She advises on healthcare innovation strategy, responsible AI adoption in health, resilient health manufacturing capability, health equity and access implementation, and cross-sector partnership architecture. Her advisory work is most relevant when institutions are deciding what to build, how to govern it, who to partner with, and how to move from ambition to implementation.

What makes her background distinctive?

Dr. Dunn combines doctoral scientific training, Harvard public-health training, founder-operator experience, digital manufacturing work, and international platform credibility. This allows her to connect technical, public-health, partnership, and implementation considerations in a way that is useful to institutions working across health innovation, access, and emerging technologies.

Is Dr. Dunn’s work relevant beyond South Africa?

Yes. While Dr. Dunn’s founder-operator experience includes African health innovation and manufacturing contexts, her work is relevant to international institutions interested in responsible AI adoption, healthcare manufacturing resilience, health equity implementation, technology transfer, and partnerships that translate innovation into practical capability.

What types of institutions are the best fit?

Best-fit conversations usually involve health systems, public institutions, universities, funders, innovation programmes, strategic partners, boards, media, and convening platforms working on healthcare innovation, responsible AI adoption, digital manufacturing, health equity, or implementation readiness.

What kinds of advisory situations are the best fit?

Best-fit situations include evaluating AI or digital health initiatives, designing healthcare manufacturing or point-of-care production models, shaping health equity and access strategies, aligning cross-sector partnerships, or preparing an expert briefing before committing institutional resources.

Is Dr. Dunn available for speaking or media?

Yes. Dr. Dunn is available for selected talks, panels, interviews, and moderated conversations on healthcare innovation beyond the pilot stage, responsible AI adoption in health systems, distributed manufacturing for healthcare resilience, health equity and access implementation, and emerging-market health innovation.

How can institutions work with her?

Institutions can request an advisory conversation through the contact form. Please include the organisation, decision context, timeline, stakeholders, and intended outcome. Relevant inquiries are reviewed directly, and if there is a clear fit, the next step is usually a short advisory conversation.

Strategic advisory for institutions building implementation-ready health innovation capability

If your institution is evaluating responsible AI adoption, resilient health manufacturing, health equity implementation, partnership governance, or a cross-sector health innovation initiative, request an advisory conversation.

Best-fit conversations include institutional advisory, partnership scoping, speaking and media requests, board or advisory roles, funder conversations, and public-sector collaborations.

Best-fit inquiries

  • Healthcare innovation strategy and implementation readiness
  • Responsible AI adoption in healthcare and public-health settings
  • Resilient health manufacturing, digital production, and point-of-care capability
  • Health equity, access models, and underserved health settings
  • Cross-sector partnership architecture and governance
  • Public-health innovation and institutional delivery models
  • Board, advisory, media, speaking, and funder conversations

Please include your organisation, decision context, timeline, and intended outcome when reaching out.

Direct institutional contact

cherise_dunn@hsph.harvard.edu

What happens after you inquire

Relevant institutional inquiries are reviewed directly. If there is a clear fit, the next step is usually a short advisory conversation to understand the decision context, stakeholders, timeline, and intended outcome.

For media, speaking, and institutional review

Download CV

For relevant advisory, partnership, speaking, media, board, or funder inquiries, Dr. Dunn will respond directly.